Details of Host Protein-DME Interaction (HOSPPI)
General Information of Drug-Metabolizing Enzyme (DME ID: DME1090) | |||||
---|---|---|---|---|---|
DME Name | Aminoglycoside phosphotransferase (aph-Ib), Campylobacter jejuni | DME Info | |||
UniProt ID | |||||
EC Number | EC: 2.7.1.190 (Click to Show/Hide the Complete EC Tree) | ||||
Lineage | Species: Campylobacter jejuni (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome |
Disease Specific Interactions between Host Protein and DME (HOSPPI) | |||||
---|---|---|---|---|---|
Drug co-metabolism | |||||
Cometabolized drug: Tobramycin | Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI | ||||
RNA cytidine acetyltransferase (hALP) | Click to Show/Hide the Cometabolization Info | ||||
DME ID | DME0007 DME Info | ||||
Uniprot ID | |||||
Interaction Name | hALP-aph-Ib interaction | [1], [2] | |||
Description | The interaction, between human RNA cytidine acetyltransferase and Aminoglycoside phosphotransferase from Campylobacter jejuni which collectively metabolize the drug Tobramycin, is reported to affect the efficacy, safety or bioavailability of this drug via interfering with it metabolism. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.